Literature DB >> 10069424

Core 2-containing O-glycans on CD43 are preferentially expressed in the memory subset of human CD4 T cells.

R Mukasa1, T Homma, T Ohtsuki, O Hosono, A Souta, T Kitamura, M Fukuda, S Watanabe, C Morimoto.   

Abstract

Human CD4 T cells can be divided into two functionally distinct subsets: a CD45RO+ memory subset and a CD45RA+ naive subset. In an attempt to identify novel cell surface molecules on these cells, we have developed a mAb, anti-1D4. The antigen defined by anti-1D4 was preferentially expressed on the memory subset of freshly isolated peripheral CD4 T cells and 1D4+ CD4 T cells functionally corresponded to memory T cells. Retrovirus-mediated expression cloning revealed that the 1 D4 antigen is human CD43. Transfection of CHO-leu cells, which stably express human CD43, with core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT) conferred expression of the 1D4 antigen and mRNA of C2GnT was detected by RT-PCR only in 1D4+ T cells but not in 1D4- T cells, implying that the 1 D4 antigen is composed of core 2-containing O-glycans on CD43. Reactivity with anti-1 D4 was completely abolished when cells were treated with neuraminidase, while them remained weak binding of anti-T305, a previously described mAb which also reacts with CD43 modified with core 2-containing O-glycans. Moreover, anti-1D4 markedly reacted with NIH-3T3 cells expressing human CD43 and low levels of endogenous C2GnT, whereas anti-T305 reacted slightly. These results indicate that the 1D4 antigen is distinct from the epitope defined by anti-T305 and anti-1D4 is a more sensitive probe to detect core 2-containing O-glycans than anti-T305. Taken together, our results indicate that core 2-containing O-glycans, whose expression can easily be detected with anti-1D4, are preferentially expressed in the CD45RO+ memory subset of CD4 T cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069424     DOI: 10.1093/intimm/11.2.259

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

1.  Haploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death.

Authors:  Paula V Cabrera; Maho Amano; Junya Mitoma; Jessica Chan; Jonathan Said; Minoru Fukuda; Linda G Baum
Journal:  Blood       Date:  2006-06-15       Impact factor: 22.113

2.  CD43 is a ligand for E-selectin on CLA+ human T cells.

Authors:  Robert C Fuhlbrigge; Sandra L King; Robert Sackstein; Thomas S Kupper
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

3.  GCNT1-Mediated O-Glycosylation of the Sialomucin CD43 Is a Sensitive Indicator of Notch Signaling in Activated T Cells.

Authors:  Eric Perkey; Dave Maurice De Sousa; Léolène Carrington; Jooho Chung; Alexander Dils; David Granadier; Ute Koch; Freddy Radtke; Burkhard Ludewig; Bruce R Blazar; Christian W Siebel; Todd V Brennan; Jeffrey Nolz; Nathalie Labrecque; Ivan Maillard
Journal:  J Immunol       Date:  2020-02-14       Impact factor: 5.422

4.  The tetraspanin CD9 is preferentially expressed on the human CD4(+)CD45RA+ naive T cell population and is involved in T cell activation.

Authors:  H Kobayashi; O Hosono; S Iwata; H Kawasaki; M Kuwana; H Tanaka; N H Dang; C Morimoto
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

5.  Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans.

Authors:  L E Harrington; M Galvan; L G Baum; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

6.  Human B Cell Differentiation Is Characterized by Progressive Remodeling of O-Linked Glycans.

Authors:  Nicholas Giovannone; Aristotelis Antonopoulos; Jennifer Liang; Jenna Geddes Sweeney; Matthew R Kudelka; Sandra L King; Gi Soo Lee; Richard D Cummings; Anne Dell; Steven R Barthel; Hans R Widlund; Stuart M Haslam; Charles J Dimitroff
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561

7.  Galectin-1 regulates tissue exit of specific dendritic cell populations.

Authors:  Sandra Thiemann; Jeanette H Man; Margaret H Chang; Benhur Lee; Linda G Baum
Journal:  J Biol Chem       Date:  2015-07-27       Impact factor: 5.157

8.  Genome-scale CRISPR activation screen uncovers tumor-intrinsic modulators of CD3 bispecific antibody efficacy.

Authors:  Corinne E Decker; Tara Young; Elizabeth Pasnikowski; Joyce Chiu; Hang Song; Yi Wei; Gavin Thurston; Christopher Daly
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.